Kervan Umit, Unal Ertekin Utku, Sert Dogan Emre, Pac Mustafa
From the Department of Cardiovascular Surgery, Turkey Yuksek Ihtisas Hospital, Ankara, Turkey.
Exp Clin Transplant. 2019 Apr;17(2):278-280. doi: 10.6002/ect.2016.0056. Epub 2016 May 26.
Left ventricular assist devices (LVADs) extend survival of patients with end-stage heart failure as a bridge to transplant or for destination therapy. However, implant of these devices may be challenging, especially in cases of a left ventricular aneurysm involving the left ventricular apical wall. In this report, we describe a symptomatic patient with ischemic cardiomyopathy and a large left ventricular anterior aneurysm treated by reconstruction of the left ventricle and simultaneous implant of the HeartWare LVAD system (HVAD; HeartWare International, Inc., Framingham, MA, USA).
左心室辅助装置(LVADs)可延长终末期心力衰竭患者的生存期,作为移植的桥梁或用于终末期治疗。然而,植入这些装置可能具有挑战性,尤其是在左心室动脉瘤累及左心室心尖壁的情况下。在本报告中,我们描述了一名有症状的缺血性心肌病患者,其患有巨大的左心室前壁动脉瘤,通过左心室重建并同时植入HeartWare左心室辅助装置系统(HVAD;美国马萨诸塞州弗雷明汉市HeartWare国际公司)进行治疗。